From combinatorial chemistry to cancer-targeting peptides.

Several monoclonal antibodies that target cell surface receptors have gained approval by the U.S. Food and Drug Administration and are widely used in the treatment of some cancers. These include but are not limited to the anti-CD20 antibody Rituximab, used in lymphoma treatment, as well as anti-HER-2 antibody for breast cancer therapy. The efficacy of this cancer immunotherapy modality is, however, limited by the large size of the antibody (160 kd) and its relatively nonspecific binding to the reticuloendothelial system. This latter property is particularly problematic if the antibody is used as a vehicle to deliver radionuclides, cytotoxic drugs, or toxins to the tumor site. Peptides, peptidomimetic, or small molecules are thus attractive as alternative cell surface targeting agents for cancer imaging and therapy. Cancer cell surface targeting peptides can be derived from known native peptide hormones such as somatostatin and bombesin, or they can be identified through screening combinatorial peptide libraries against unknown cell surface receptor targets. Phage-display peptide library and one-bead one-compound (OBOC) combinatorial library methods have been successfully used to discover peptides that target cancer cells or tumor blood vessel endothelial cells. The phage-display peptide library method, because of its biological nature, can only display l-amino acid peptides. In contrast, the OBOC combinatorial library method allows for bead-surface display of peptides that contain l-amino acids, d-amino acids, unnatural amino acids, or other organic moieties. We have successfully used the OBOC method to discover and optimize ligands against unique cell surface receptors of prostate cancer, T- and B-cell lymphoma, as well as ovarian and lung cancers, and we have used some of these peptides to image xenografts in nude mice with high specificity. Here, we (i) review the literature on the use of phage-display and OBOC combinatorial library methods to discover cancer and tumor blood vessel targeting ligands, and (ii) report on the use of an ovarian cancer targeting ligand, OA02, as an in vivo PET imaging probe in a xenograft model in nude mice.

[1]  K. Lam,et al.  Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research. , 2003, Accounts of chemical research.

[2]  M J Welch,et al.  Efficient production of high specific activity 64Cu using a biomedical cyclotron. , 1997, Nuclear medicine and biology.

[3]  K. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[4]  B. Pützer,et al.  Discovery of targeting peptides for selective therapy of medullary thyroid carcinoma , 2005, The journal of gene medicine.

[5]  B. Ponder,et al.  Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection. , 2005, Human gene therapy.

[6]  D. Solas,et al.  Screening for Novel Antimicrobials from Encoded Combinatorial Libraries by Using a Two-Dimensional Agar Format , 1998, Antimicrobial Agents and Chemotherapy.

[7]  Erkki Ruoslahti,et al.  Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display , 2007, Molecular Cancer Research.

[8]  H. Fenniri,et al.  Barcoded resins: a new concept for polymer-supported combinatorial library self-deconvolution. , 2001, Journal of the American Chemical Society.

[9]  V. Raman,et al.  Real time non‐invasive imaging of receptor–ligand interactions in vivo , 2003, Journal of cellular biochemistry.

[10]  M. Meldal,et al.  Portion-mixing peptide libraries of quenched fluorogenic substrates for complete subsite mapping of endoprotease specificity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Wellstein,et al.  A secreted FGF-binding protein can serve as the angiogenic switch in human cancer , 1997, Nature Medicine.

[12]  Jennifer L. Harris,et al.  PNA-encoded protease substrate microarrays. , 2004, Chemistry & biology.

[13]  Xianzhong Zhang,et al.  Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. , 2006, Nuclear medicine and biology.

[14]  K. Lam,et al.  Structure–activity relationship studies of a series of peptidomimetic ligands for α4 β1 integrin on Jurkat T‐leukemia cells , 2006 .

[15]  E. York,et al.  Combination cancer chemotherapy with one compound: Pluripotent bradykinin antagonists , 2005, Peptides.

[16]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[17]  H. Spring,et al.  Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. , 2001, Cancer letters.

[18]  U. Stenman,et al.  Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity. , 2000, European journal of biochemistry.

[19]  Han-Chung Wu,et al.  A Novel Peptide Specifically Binding to Nasopharyngeal Carcinoma For Targeted Drug Delivery , 2004, Cancer Research.

[20]  K. Brown,et al.  Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas. , 2006, Experimental hematology.

[21]  Kit S Lam,et al.  Therapeutic cancer targeting peptides. , 2002, Biopolymers.

[22]  Stephen Albert Johnston,et al.  In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo. , 2004, Journal of molecular biology.

[23]  Kit S Lam,et al.  Near-Infrared Optical Imaging of Ovarian Cancer Xenografts with Novel α3-Integrin Binding Peptide “OA02” , 2005, Molecular imaging.

[24]  E. Ruoslahti,et al.  Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  V. Petrenko,et al.  Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion , 2001, The Prostate.

[26]  Peter S. Conti,et al.  MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  J. Verweij,et al.  Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours , 2003 .

[28]  R. Frank.  The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. , 2002, Journal of immunological methods.

[29]  Donald L Weaver,et al.  Selection of tumor-binding ligands in cancer patients with phage display libraries. , 2006, Cancer research.

[30]  E. Ruoslahti,et al.  A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. , 2000, Cancer research.

[31]  Sanjiv S. Gambhir,et al.  Near-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3 Expression in Living Mice , 2005 .

[32]  Shuang Liu.  Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging , 2006 .

[33]  Joonyoung Kim,et al.  MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. , 2003, Bioconjugate chemistry.

[34]  Kim-Anh Do,et al.  Steps toward mapping the human vasculature by phage display , 2002, Nature Medicine.

[35]  K. Lam,et al.  Peptide ligands targeting integrin a31 in non-small cell lung cancer , 2006 .

[36]  M. Brandi,et al.  Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma. , 2007, Anticancer research.

[37]  R. Pasqualini.  Vascular targeting with phage peptide libraries. , 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[38]  C. Buckley,et al.  Identification of synovium-specific homing peptides by in vivo phage display selection. , 2002, Arthritis and rheumatism.

[39]  T. Keough,et al.  GENERATION AND SCREENING OF COMBINATORIAL PEPTIDE LIBRARIES DESIGNED FOR RAPID SEQUENCING BY MASS SPECTROMETRY , 1995 .

[40]  E. Levin,et al.  Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2. , 2004, The American journal of pathology.

[41]  H. Vogel,et al.  In Vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in an Orthotopic Glioblastoma Model , 2006, Molecular Imaging and Biology.

[42]  Sharon Bloch,et al.  Targeting Beta-3 integrin using a linear hexapeptide labeled with a near-infrared fluorescent molecular probe. , 2006, Molecular pharmaceutics.

[43]  D. Krag,et al.  Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library. , 2005, Oncology reports.

[44]  D. Hanahan,et al.  Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. , 2003, Cancer cell.

[45]  D. Santi,et al.  Identification of highest-affinity ligands by affinity selection from equimolar peptide mixtures generated by robotic synthesis , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Peter S. Conti,et al.  Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression , 2004 .

[47]  Zhiyuan Hu,et al.  Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library , 2007, Journal of biomolecular screening.

[48]  Eva M. Sevick-Muraca,et al.  Quantifying molecular specificity of αvβ3 integrin-targeted optical contrast agents with dynamic optical imaging , 2005 .

[49]  M. Ozawa,et al.  Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection. , 2005, The American journal of pathology.

[50]  K. Lam,et al.  The use of a combinatorial library method to isolate human tumor cell adhesion peptides , 1996, Molecular Diversity.

[51]  T. Kodadek,et al.  Quantum Dots As A Visual Aid For Screening Bead‐Bound Combinatorial Libraries , 2003, Chembiochem : a European journal of chemical biology.

[52]  U. Haberkorn,et al.  A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[53]  K. Sekiguchi,et al.  Novel Peptide Ligands for Integrin α6β1 Selected from a Phage Display Library , 1996 .

[54]  R. Aitken,et al.  Selection of Peptides Targeting the Human Sperm Surface Using Random Peptide Phage Display Identify Ligands Homologous to ZP3 , 2000, Biology of reproduction.

[55]  Wadih Arap,et al.  Synchronous selection of homing peptides for multiple tissues by in vivo phage display , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  Stephen Albert Johnston,et al.  Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. , 2003, Cancer letters.

[57]  A. Prats,et al.  Antiangiogenic Properties of Fibstatin, an Extracellular FGF-2–Binding Polypeptide , 2004, Cancer Research.

[58]  R. Frank.  Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support , 1992 .

[59]  Erkki Ruoslahti,et al.  Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins , 1995, Bio/Technology.

[60]  R. W. Armstrong,et al.  Radio Frequency Tag Encoded Combinatorial Library Method for the Discovery of Tripeptide-Substituted Cinnamic Acid Inhibitors of the Protein Tyrosine Phosphatase PTP1B , 1995 .

[61]  Bruce F. Smith,et al.  Elucidation of muscle‐binding peptides by phage display screening , 1999, Muscle & nerve.

[62]  Miao Wu,et al.  In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. , 2006, Biochemical and biophysical research communications.

[63]  T. Saga,et al.  Renal metabolism of 3'-iodohippuryl N(epsilon)-maleoyl-L-lysine (HML)-conjugated Fab fragments. , 2001, Bioconjugate chemistry.

[64]  Ruiwu Liu,et al.  Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging , 2006 .

[65]  Erkki Ruoslahti,et al.  Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. , 2003, Cancer cell.

[66]  Rex Moats,et al.  18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. , 2004, Nuclear medicine and biology.

[67]  N. Neamati,et al.  Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. , 2005, Journal of medicinal chemistry.

[68]  E. Ruoslahti,et al.  Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. , 1993, The Journal of biological chemistry.

[69]  J. Posey,et al.  A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer. , 2001, Cancer biotherapy & radiopharmaceuticals.

[70]  Michael V. Doyle,et al.  Semirational design of a potent, artificial agonist of fibroblast growth factor receptors , 1999, Nature Biotechnology.

[71]  Erkki Ruoslahti,et al.  Targeting the prostate for destruction through a vascular address , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Kit S. Lam,et al.  High-volume cellular screening for anticancer agents with combinatorial chemical libraries: A new methodology , 1996, Molecular Diversity.

[73]  K. Lam,et al.  The minimum element of a synthetic peptide required to block prostate tumor cell migration , 2006, Cancer biology & therapy.

[74]  Ralph Weissleder,et al.  In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. , 2006, Neoplasia.

[75]  Kit S Lam,et al.  From combinatorial chemistry to chemical microarray. , 2002, Current opinion in chemical biology.

[76]  S J Rodda,et al.  A priori delineation of a peptide which mimics a discontinuous antigenic determinant. , 1986, Molecular immunology.

[77]  Erkki Ruoslahti,et al.  A tumor-homing peptide with a targeting specificity related to lymphatic vessels , 2002, Nature Medicine.

[78]  J. Thiery,et al.  FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo , 1997, Oncogene.

[79]  B. Chait,et al.  Protein ladder sequencing. , 1993, Science.

[80]  Sanyog Jain,et al.  Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting , 2004, Journal of drug targeting.

[81]  K. Lam,et al.  Encoding method for OBOC small molecule libraries using a biphasic approach for ladder-synthesis of coding tags. , 2004, Journal of the American Chemical Society.

[82]  C. Jayawickreme,et al.  Use of a cell-based, lawn format assay to rapidly screen a 442,368 bead-based peptide library. , 1999, Journal of pharmacological and toxicological methods.

[83]  M. Schwab,et al.  Preclinical Evaluation of the Breast Cancer Cell-Binding Peptide, p160 , 2005, Clinical Cancer Research.

[84]  A. Epenetos,et al.  Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide , 1998, European Journal of Nuclear Medicine.

[85]  R Pasqualini,et al.  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. , 2000, Cancer research.

[86]  B. Bernard,et al.  Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[87]  H. Tsukada,et al.  Anti-neovascular therapy using novel peptides homing to angiogenic vessels , 2002, Oncogene.

[88]  J. Devlin,et al.  Random peptide libraries: a source of specific protein binding molecules. , 1990, Science.

[89]  W. Semmler,et al.  Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands , 2001, Nature Biotechnology.

[90]  M. Schwaiger,et al.  PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[91]  H. Coste,et al.  Self-deciphering, orthogonal combinatorial libraries of soluble organic compounds: Discovery of a potent V2 vasopressin antagonist , 1995 .

[92]  Ryan Park,et al.  MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. , 2004, Bioconjugate chemistry.

[93]  E. Ruoslahti,et al.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.

[94]  R. Houghten,et al.  Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery , 1991, Nature.

[95]  K. Nicolaou,et al.  Radiofrequency Encoded Combinatorial Chemistry , 1995 .

[96]  K. Lam,et al.  Synthesis of hydrophilic and flexible linkers for peptide derivatization in solid phase. , 2004, Bioorganic & medicinal chemistry letters.

[97]  K. Lam,et al.  Partial alloc-deprotection approach for ladder synthesis of "one-bead one-compound" combinatorial libraries. , 2005, Journal of combinatorial chemistry.

[98]  R Pasqualini,et al.  Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. , 1998, The Journal of clinical investigation.

[99]  W. Martin,et al.  Mapping alveolar binding sites in vivo using phage peptide libraries , 2003, Gene Therapy.

[100]  M. Meldal.  The one-bead two-compound assay for solid phase screening of combinatorial libraries. , 2002, Biopolymers.

[101]  C. Wood,et al.  Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands. , 2003, The Journal of urology.

[102]  Ryan Park,et al.  MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[103]  H. J. Baker,et al.  Phage probes for malignant glial cells. , 2003, Molecular cancer therapeutics.

[104]  Young-Seung Kim,et al.  Evaluation of a 99mTc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin αvβ3-Positive Breast Cancer , 2007 .

[105]  S. P. Fodor,et al.  Light-directed, spatially addressable parallel chemical synthesis. , 1991, Science.

[106]  K. Brown,et al.  Cell-specific delivery of a chemotherapeutic to lung cancer cells. , 2004, Journal of the American Chemical Society.

[107]  L. Buhl,et al.  Surface immunoglobulin on B lymphocytes as a potential target for specific peptide ligands in chronic lymphocytic leukaemia , 2002, British journal of haematology.

[108]  Kit S Lam,et al.  A novel peptide-based encoding system for "one-bead one-compound" peptidomimetic and small molecule combinatorial libraries. , 2002, Journal of the American Chemical Society.

[109]  B. Kay,et al.  Screening phage-displayed combinatorial peptide libraries. , 2001, Methods.

[110]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[111]  H. M. Geysen,et al.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[112]  Kit S Lam,et al.  Identification of novel targeting peptides for human ovarian cancer cells using “one-bead one-compound” combinatorial libraries , 2005, Molecular Cancer Therapeutics.

[113]  Britton Chance,et al.  Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[114]  K. Lam,et al.  A novel and rapid encoding method based on mass spectrometry for "one-bead-one-compound" small molecule combinatorial libraries. , 2003, Journal of the American Chemical Society.

[115]  Kit S. Lam,et al.  The “One-Bead-One-Compound” Combinatorial Library Method , 1997 .

[116]  K. Lam,et al.  The use of one-bead one-compound combinatorial library method to identify peptide ligands for α4β1 integrin receptor in non-Hodgkin's lymphoma , 2001, Letters in Peptide Science.

[117]  E. Ruoslahti,et al.  Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[118]  Eduard Schreibmann,et al.  18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[119]  R. Houghten,et al.  The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands. , 1993, Life sciences.

[120]  G. Clayman,et al.  Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. , 2000, Cancer research.

[121]  Kim-Anh Do,et al.  Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. , 2006, Cancer research.

[122]  Angelo Corti,et al.  Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. , 2002, The Journal of clinical investigation.

[123]  K. Lam,et al.  Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins. , 2001, Cancer research.

[124]  R. Barrett,et al.  Peptides on phage: a vast library of peptides for identifying ligands. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[125]  V. Alakhov,et al.  A Vascular Endothelial Growth Factor High Affinity Receptor 1-specific Peptide with Antiangiogenic Activity Identified Using a Phage Display Peptide Library* , 2003, Journal of Biological Chemistry.

[126]  Sharon Bloch,et al.  Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. , 2006, Journal of medicinal chemistry.

[127]  Ralph Weissleder,et al.  Detection of Invasive Colon Cancer Using a Novel, Targeted, Library-Derived Fluorescent Peptide , 2004, Cancer Research.

[128]  David A Jones,et al.  Isolation of a colon tumor specific binding peptide using phage display selection. , 2003, Neoplasia.

[129]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[130]  Bradley B. Brown,et al.  A single-bead decode strategy using electrospray ionization mass spectrometry and a new photolabile linker: 3-Amino-3-(2-nitrophenyl)propionic acid , 1995, Molecular Diversity.

[131]  H. J. Baker,et al.  Targeting peptides for microglia identified via phage display , 2002, Journal of Neuroimmunology.

[132]  Ryan Park,et al.  Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. , 2004, Molecular imaging.

[133]  M Schwaiger,et al.  Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.